BIONEXUS GENE LAB CORP COMMON STOCK

NASDAQ: BGLC (BioNexus Gene Lab Corp)

Last update: 15 Jan, 7:19AM

0.346

0.01 (3.28%)

Previous Close 0.335
Open 0.340
Volume 3,274,845
Avg. Volume (3M) 4,079,808
Market Cap 6,216,824
Price / Sales 0.530
Price / Book 0.520
52 Weeks Range
0.211 (-39%) — 3.39 (879%)
Profit Margin -16.81%
Operating Margin (TTM) -26.79%
Diluted EPS (TTM) -0.610
Quarterly Revenue Growth (YOY) 11.00%
Total Debt/Equity (MRQ) 2.74%
Current Ratio (MRQ) 3.81
Operating Cash Flow (TTM) -2.23 M
Levered Free Cash Flow (TTM) -1.91 M
Return on Assets (TTM) -10.86%
Return on Equity (TTM) -17.78%

Market Trend

Short Term Medium Term
Industry Specialty Chemicals (US) Bearish Bearish
Specialty Chemicals (Global) Bearish Bearish
Stock BioNexus Gene Lab Corp - -

AIStockmoo Score

-1.4
Analyst Consensus -2.0
Insider Activity NA
Price Volatility 3.0
Technical Moving Averages -2.5
Technical Oscillators -4.0
Average -1.38

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
BGLC 6 M - - 0.520
CLMT 812 M - - 19.32
HDSN 261 M - 8.89 0.940
FEAM 77 M - - 9.88
ALTO 68 M - - 0.270
CNEY 6 M - - 0.020

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Sector Basic Materials
Industry Specialty Chemicals
Investment Style Small Value
% Held by Insiders 49.09%
% Held by Institutions 0.99%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria